Peer Reviewed Publications
The Economic Benefits of Pharmaceutical Innovations: The Case of Cox-2 Inhibitors, American Economic Journal: Applied Economics 2012 4(3): 116-137.
The Doctor Might See You Now: Supply Side Effects of Public Health Insurance Expansions, American Economic Journal: Economic Policy 2012 4(3): 190-217.
Can Celebrity Endorsements Affect Political Outcomes? Evidence from the 2008 U.S. Democratic Presidential Primary (with Timothy J. Moore), The Journal of Law, Economics, and Organization, 2013, 29(2): 355-384.
Giving Mom a Break: The Impact of Higher EITC Payments on Maternal Health (with William Evans), American Economic Journal: Economic Policy, 2014, 6(2): 258-290.
Demand Spillovers, Combative Advertising, and Celebrity Endorsements, American Economic Journal: Applied Economics, 2014, 6(2); 76-104.
The White/Black Educational Gap, Stalled Progress, and the Long Term Consequences of the Emergence of Crack Cocaine Markets, NBER Working Paper #18437, under review, March 2014 (with William Evans and Timothy J. Moore)
Works in Progress
Hospitals as Insurers of Last Resort (with Tal Gross and Matthew Notowidigdo)
Income Shocks and Health Insurance Enrollment (with David Dranove and Chris Ody)
Permanent Working Papers
Empirical Evidence on the Value of Pharmaceuticals, (with Mark Duggan), in The [Oxford]
Handbook of the Economics of the Biopharmaceutical Industry, forthcoming, 2010.
Starbucks: A Story of Growth, (with Jen Brown and Meghan Busse), 2011. Kellogg Case #5-211-259.
The Global Aircraft Manufacturing Industry, 2002-2011 (with Jen Brown), 2012. Kellogg Case #5-312-505.